Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate - PubMed (original) (raw)
Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate
E J Simon et al. Proc Natl Acad Sci U S A. 1973 Jul.
Abstract
Etorphine, the most potent narcotic analgesic known, was labeled with tritium by catalytic exchange. This drug exhibits stereospecific, saturable binding to rat-brain homogenate. At saturation, the stereospecific binding is 0.1-0.15 pmol/mg of protein. Specific binding is inhibited high salt concentrations, sulfhydryl reagents, and proteolytic enzymes, but is unaffected by phospholipases A and C, sodium azide, sodium fluoride, and prostaglandins E(1) and E(2). Competition for binding of [(3)H]etorphine correlates with agonist and antagonist potencies. The stable, stereospecific binding of an active narcotic analgesic supports the existence of opiate receptors.
Similar articles
- Properties of opiate-receptor binding in rat brain.
Pert CB, Snyder SH. Pert CB, et al. Proc Natl Acad Sci U S A. 1973 Aug;70(8):2243-7. doi: 10.1073/pnas.70.8.2243. Proc Natl Acad Sci U S A. 1973. PMID: 4525427 Free PMC article. - Solubilization of a stereospecific opiate-macromolecular complex from rat brain.
Simon EJ, Hiller JM, Edelman I. Simon EJ, et al. Science. 1975 Oct 24;190(4212):389-90. doi: 10.1126/science.1182043. Science. 1975. PMID: 1182043 - Stereospecific binding of narcotics to brain cerebrosides.
Loh HH, Cho TM, Wu YC, Way EL. Loh HH, et al. Life Sci. 1974 Jun 1;14(11):2231-45. doi: 10.1016/0024-3205(74)90105-2. Life Sci. 1974. PMID: 4847814 No abstract available. - In search of the opiate receptor.
Simon EJ. Simon EJ. Am J Med Sci. 1973 Sep;266(3):160-8. doi: 10.1097/00000441-197309000-00001. Am J Med Sci. 1973. PMID: 4583407 Review. No abstract available. - Interactions of narcotic antagonists with receptor sites.
Goldstein A. Goldstein A. Adv Biochem Psychopharmacol. 1973;8(0):471-81. Adv Biochem Psychopharmacol. 1973. PMID: 4212101 Review. No abstract available.
Cited by
- Animal and molecular pharmacology of mixed agonist-antagonist analgesic drugs.
Rance MJ. Rance MJ. Br J Clin Pharmacol. 1979;7 Suppl 3(Suppl 3):281S-286S. doi: 10.1111/j.1365-2125.1979.tb04701.x. Br J Clin Pharmacol. 1979. PMID: 223616 Free PMC article. - Naloxone-induced reversal of schizophrenic hallucinations.
Gunne LM, Lindström L, Terenius L. Gunne LM, et al. J Neural Transm. 1977;40(1):13-9. doi: 10.1007/BF01250276. J Neural Transm. 1977. PMID: 319204 Clinical Trial. - Copper complexes of non-steroidal antiinflammatory agents: analgesic activity and possible opioid receptor activation.
Okuyama S, Hashimoto S, Aihara H, Willingham WM, Sorenson JR. Okuyama S, et al. Agents Actions. 1987 Jun;21(1-2):130-44. doi: 10.1007/BF01974933. Agents Actions. 1987. PMID: 2820213 - Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands.
Sturaro C, Malfacini D, Argentieri M, Djeujo FM, Marzola E, Albanese V, Ruzza C, Guerrini R, Calo' G, Molinari P. Sturaro C, et al. Front Pharmacol. 2022 Apr 21;13:873082. doi: 10.3389/fphar.2022.873082. eCollection 2022. Front Pharmacol. 2022. PMID: 35529436 Free PMC article. - Neuromarkers in addiction: definitions, development strategies, and recent advances.
Harp NR, Wager TD, Kober H. Harp NR, et al. J Neural Transm (Vienna). 2024 May;131(5):509-523. doi: 10.1007/s00702-024-02766-2. Epub 2024 Apr 17. J Neural Transm (Vienna). 2024. PMID: 38630190 Review.
References
- Proc Soc Exp Biol Med. 1966 May;122(1):6-11 - PubMed
- Biochem Biophys Res Commun. 1966 Apr 6;23(1):68-74 - PubMed
- Br J Pharmacol Chemother. 1967 May;30(1):11-22 - PubMed
- J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
- Proc Natl Acad Sci U S A. 1971 Aug;68(8):1742-7 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases